|Articles|March 10, 2023
- Pharmaceutical Executive: March 2023
- Volume 43
- Issue 3
Pharmaceutical Executive, March 2023 Issue (PDF)
Advertisement
Articles in this issue
about 3 years ago
Navigating Disruption in the Metapharma Eraabout 3 years ago
Biopharma M&A: Year in Review, Ripples Aheadabout 3 years ago
Balancing Pharma Hiring Practices in Good Times and Badabout 3 years ago
Being KOL-Centric: More Meaningful Expert Engagementabout 3 years ago
A New Era of Influence: Embracing the KOL-DOL Dynamic in Healthcareabout 3 years ago
Food for Thought: Make Room for Multiple Opinionsabout 3 years ago
The Pivot to Digitalabout 3 years ago
More than Ever, Data Will Dictate Future Fortunesabout 3 years ago
Generative AI’s Breakthrough Potential in Pharma Marketingabout 3 years ago
The Challenge of Taking on Falsified Medicines in EuropeAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA’s Advisory Panel Votes in Favor of Updating Covid-19 Vaccine Shots to Target XFG Variant
2
CVS Restores Coverage of Lilly’s Zepbound, Adds Oral Obesity Drug Foundayo
3
WHO Prioritizes Three Experimental Treatments for Bundibugyo Ebola Strain
4
FDA's Timeline for DTC Prescription Drug Ad Oversight
5